Research Summary
mRNA (messenger RNA) vaccines and therapeutics are a groundbreaking class of medical treatments and preventive measures that use synthetic strands of messenger RNA to instruct cells in the body to produce specific proteins or trigger immune responses. In the context of vaccines, mRNA vaccines have gained significant attention for their role in protecting against infectious diseases, such as COVID-19. They work by introducing a small piece of synthetic mRNA that codes for a harmless part of the target pathogen, prompting the immune system to produce an immune response. Similarly, in therapeutics, mRNA can be used to instruct cells to create therapeutic proteins, offering potential treatments for various medical conditions, including genetic diseases and cancer. mRNA technology has shown great promise due to its flexibility, rapid development potential, and adaptability in responding to emerging health challenges, marking a significant advancement in the fields of vaccination and medical treatment.
According to DIResearch's in-depth investigation and research, the global mRNA Vaccines and Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of mRNA Vaccines and Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of mRNA Vaccines and Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global mRNA Vaccines and Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the mRNA Vaccines and Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of mRNA Vaccines and Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of mRNA Vaccines and Therapeutics Include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA Vaccines and Therapeutics Product Segment Include:
Vaccines
Therapeutics
mRNA Vaccines and Therapeutics Product Application Include:
Disease Prevention Market
Tumor Immunity Market
Protein Replacement Therapy Market
Regenerative Therapy Market
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global mRNA Vaccines and Therapeutics Industry PESTEL Analysis
Chapter 3: Global mRNA Vaccines and Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global mRNA Vaccines and Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global mRNA Vaccines and Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global mRNA Vaccines and Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 mRNA Vaccines and Therapeutics Market Overview 1.1 Product Definition and Statistical Scope 1.2 mRNA Vaccines and Therapeutics Product by Type 1.2.1 Global mRNA Vaccines and Therapeutics Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Vaccines 1.2.3 Therapeutics 1.3 mRNA Vaccines and Therapeutics Product by Application 1.3.1 Global mRNA Vaccines and Therapeutics Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Disease Prevention Market 1.3.3 Tumor Immunity Market 1.3.4 Protein Replacement Therapy Market 1.3.5 Regenerative Therapy Market 1.4 Global mRNA Vaccines and Therapeutics Market Revenue Analysis (2019-2030) 1.5 mRNA Vaccines and Therapeutics Market Development Status and Trends 1.5.1 mRNA Vaccines and Therapeutics Industry Development Status Analysis 1.5.2 mRNA Vaccines and Therapeutics Industry Development Trends Analysis 2 mRNA Vaccines and Therapeutics Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 mRNA Vaccines and Therapeutics Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global mRNA Vaccines and Therapeutics Market Analysis by Regions 4.1 mRNA Vaccines and Therapeutics Overall Market: 2023 VS 2024 VS 2030 4.2 Global mRNA Vaccines and Therapeutics Revenue and Forecast Analysis (2019-2030) 4.2.1 Global mRNA Vaccines and Therapeutics Revenue and Market Share by Region (2019-2024) 4.2.2 Global mRNA Vaccines and Therapeutics Revenue Forecast by Region (2025-2030) 5 Global mRNA Vaccines and Therapeutics Market Size by Type and Application 5.1 Global mRNA Vaccines and Therapeutics Market Size by Type 5.2 Global mRNA Vaccines and Therapeutics Market Size by Application 6 North America 6.1 North America mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America mRNA Vaccines and Therapeutics Market Size by Type 6.4 North America mRNA Vaccines and Therapeutics Market Size by Application 6.5 North America mRNA Vaccines and Therapeutics Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe mRNA Vaccines and Therapeutics Market Size by Type 7.4 Europe mRNA Vaccines and Therapeutics Market Size by Application 7.5 Europe mRNA Vaccines and Therapeutics Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China mRNA Vaccines and Therapeutics Market Size by Type 8.4 China mRNA Vaccines and Therapeutics Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) mRNA Vaccines and Therapeutics Market Size by Type 9.4 APAC (excl. China) mRNA Vaccines and Therapeutics Market Size by Application 9.5 APAC (excl. China) mRNA Vaccines and Therapeutics Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America mRNA Vaccines and Therapeutics Market Size by Type 10.4 Latin America mRNA Vaccines and Therapeutics Market Size by Application 10.5 Latin America mRNA Vaccines and Therapeutics Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa mRNA Vaccines and Therapeutics Market Size by Type 11.4 Middle East & Africa mRNA Vaccines and Therapeutics Market Size by Application 11.5 Middle East & Africa mRNA Vaccines and Therapeutics Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global mRNA Vaccines and Therapeutics Market Revenue by Key Manufacturers (2020-2024) 12.2 mRNA Vaccines and Therapeutics Competitive Landscape Analysis and Market Dynamic 12.2.1 mRNA Vaccines and Therapeutics Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Moderna Therapeutics 13.1.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Portfolio 13.1.3 Moderna Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 CureVac 13.2.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 CureVac mRNA Vaccines and Therapeutics Product Portfolio 13.2.3 CureVac mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Translate Bio 13.3.1 Translate Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Translate Bio mRNA Vaccines and Therapeutics Product Portfolio 13.3.3 Translate Bio mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 BioNTech 13.4.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 BioNTech mRNA Vaccines and Therapeutics Product Portfolio 13.4.3 BioNTech mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Sangamo Therapeutics 13.5.1 Sangamo Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Portfolio 13.5.3 Sangamo Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Argos Therapeutics 13.6.1 Argos Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Argos Therapeutics mRNA Vaccines and Therapeutics Product Portfolio 13.6.3 Argos Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 In-Cell-Art 13.7.1 In-Cell-Art Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 In-Cell-Art mRNA Vaccines and Therapeutics Product Portfolio 13.7.3 In-Cell-Art mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 eTheRNA 13.8.1 eTheRNA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 eTheRNA mRNA Vaccines and Therapeutics Product Portfolio 13.8.3 eTheRNA mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Ethris 13.9.1 Ethris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Ethris mRNA Vaccines and Therapeutics Product Portfolio 13.9.3 Ethris mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Tiba Biotechnology 13.10.1 Tiba Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Portfolio 13.10.3 Tiba Biotechnology mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 mRNA Vaccines and Therapeutics Industry Chain Analysis 14.2 mRNA Vaccines and Therapeutics Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 mRNA Vaccines and Therapeutics Typical Downstream Customers 14.4 mRNA Vaccines and Therapeutics Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support